<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR116">
 <label>116.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Parker</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Touchette</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Oberle</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Almond</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Robertson</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Trost</surname>
    <given-names>LC</given-names>
   </name>
   <name>
    <surname>Lampert</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Painter</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Buller</surname>
    <given-names>RM</given-names>
   </name>
  </person-group>
  <article-title>Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model</article-title>
  <source>Antivir Res.</source>
  <year>2008</year>
  <volume>77</volume>
  <fpage>39</fpage>
  <lpage>49</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2007.08.003</pub-id>
  <?supplied-pmid 17904231?>
  <pub-id pub-id-type="pmid">17904231</pub-id>
 </element-citation>
</ref>
